0001857713-21-000001.txt : 20210421
0001857713-21-000001.hdr.sgml : 20210421
20210420203153
ACCESSION NUMBER: 0001857713-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210421
DATE AS OF CHANGE: 20210420
EFFECTIVENESS DATE: 20210421
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RxMP Therapeutics, Inc.
CENTRAL INDEX KEY: 0001857713
IRS NUMBER: 823928186
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-396539
FILM NUMBER: 21839249
BUSINESS ADDRESS:
STREET 1: 790 N.W. 107TH AVENUE
STREET 2: #215
CITY: MIAMI
STATE: FL
ZIP: 33172
BUSINESS PHONE: 215-872-9055
MAIL ADDRESS:
STREET 1: 790 N.W. 107TH AVENUE
STREET 2: #215
CITY: MIAMI
STATE: FL
ZIP: 33172
D
1
primary_doc.xml
X0708
D
LIVE
0001857713
RxMP Therapeutics, Inc.
790 N.W. 107TH AVENUE
#215
MIAMI
FL
FLORIDA
33172
215-872-9055
FLORIDA
RxMP Therapeutics, LLC
None
Corporation
true
2017
Rifat
Pamukcu
790 N.W. 107th Avenue
#215
Miami
FL
FLORIDA
33172
Executive Officer
Director
Promoter
Jy
Wenche
790 N.W. 107th Avenue
#215
Miami
FL
FLORIDA
33172
Executive Officer
Director
Promoter
Sue
Van
790 N.W. 107th Avenue
#215
Miami
FL
FLORIDA
33172
Director
Biotechnology
Decline to Disclose
- 06b
false
2021-03-31
false
true
false
10000
3000000
1013023
1986977
true
4
39
0
0
0
false
RxMP Therapeutics, Inc.
/s/ Rifat Pamukcu
Rifat Pamukcu
Chief Executive Officer
2021-04-20